Encompass Health Co. (NYSE:EHC) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lessened its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 6.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,413 shares of the company's stock after selling 5,011 shares during the period. Jane Street Group LLC owned 0.07% of Encompass Health worth $6,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Transce3nd LLC bought a new position in shares of Encompass Health in the 4th quarter worth about $40,000. CBIZ Investment Advisory Services LLC boosted its stake in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after acquiring an additional 127 shares during the period. Tompkins Financial Corp acquired a new stake in shares of Encompass Health in the 4th quarter worth about $46,000. Finally, V Square Quantitative Management LLC grew its position in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Up 0.4%

EHC traded up $0.47 during midday trading on Monday, reaching $116.88. 687,735 shares of the company were exchanged, compared to its average volume of 687,255. The company has a market cap of $11.78 billion, a price-to-earnings ratio of 26.21, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company's fifty day moving average price is $103.77 and its 200 day moving average price is $100.16. Encompass Health Co. has a one year low of $82.74 and a one year high of $118.27.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Encompass Health's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.12 earnings per share. As a group, analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.58%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is currently 14.05%.

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider now directly owns 11,958 shares of the company's stock, valued at $1,394,422.38. This trade represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 19,321 shares of company stock worth $2,142,452 over the last quarter. 2.00% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on EHC shares. KeyCorp lifted their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Sunday. UBS Group upped their price target on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Barclays raised their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Nine investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.